Skip to main content
Premium Trial:

Request an Annual Quote

Agencourt, Affymetrix, Nugen Collaborate on RNA Expression-Analysis Service

NEW YORK (GenomeWeb News) — Agencourt, Affymetrix, and Nugen said yesterday they have created an automated service to target and prep RNA from blood samples for expression profiling projects conducted on Affy’s GeneChip micorarrays.
 
The collaboration will support an RNA-amplification system that uses NuGen’s Ovation Whole Blood technology and automates Agencourt’s RNAdvance using Beckman Coulter’s ArrayPlex.
 
The collaboration also uses Agencourt’s RNAClean kit and SPRIPlate magnet plates.  
 
The companies said the expression-analysis service will be useful to pharmaceutical companies and government agencies seeking new biomarkers, and for academic labs that require high-throughput applications.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.